Skip to content

Clinical observation of modified Buzhong Yiqi decoction combined with PKEP in the treatment of BPH with DU

Urology

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006857
Enrollment
Unknown
Registered
2022-12-09
Start date
2022-12-09
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia

Interventions

Control group:Plasma enucleation of prostate
Test group:Modified Buzhong Yiqi decoction+Plasma enucleation of prostate

Sponsors

Fangcun Hospital, Guangdong Provincial Hospital of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Male aged 60-80 years old 2. The diagnosis conforms to the diagnostic criteria of western medicine and traditional Chinese medicine for benign prostatic hyperplasia, and urodynamics indicates that detrusor contractility is weak or no contraction (BCI < 100or Pdet@Qmax < 40cmH2O) 3.PSA, digital intestinal examination and imaging are not abnormal. Prostate cancer should be excluded by prostate puncture if there are abnormalities. 4. The patient agreed to participate in the trial and signed the informed consent form. 5. The American Society of Anesthesia score (ASA) was rated 1-3.

Exclusion criteria

Exclusion criteria: 1. At present, it has been or will be included in other trials 2. The contractile force of detrusor is normal. Suffering from stress urinary incontinence, need to be treated or use a urine pad; 4. Suffering from urethral stricture or bladder neck obstruction; 5. History of prostate and bladder surgery; 6. Suffering from progressive malignant tumor or chronic consumptive disease; 7. The patient was complicated with severe cardiopulmonary disease or severe mental disorder. Combined with active infection; 9. Severe coagulation dysfunction

Design outcomes

Primary

MeasureTime frame
Incidence of complications such as urinary incontinence;Success rate of catheter removal after operation;

Secondary

MeasureTime frame
Residual urine;Profit rate;Maximum urinary flow rate;

Countries

China

Contacts

Public Contactzhichao wang

Fangcun Hospital, Guangdong Provincial Hospital of traditional Chinese Medicine

13602495696@163.com13602495696

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026